Collectively, these findings reveal a previously unrecognized CH25H–25HC–STING axis in MDSC‐mediated immune regulation and suggest that targeting cholesterol metabolism may provide a promising therapeutic strategy for CRC immunotherapy. The gene discussed is STING1; the disease is colorectal carcinoma.